Sixteenth Board Meeting

Mr Luis Riera Figueras from the European Commission (Belgium, Finland, Portugal) constituency is designated as Rapporteur for the Sixteenth Board Meeting.

The agenda for the Sixteenth Board Meeting (GF/B16/1 Revision 2) is approved.

The report of the Fifteenth Board Meeting (GF/B16/2) is approved, as amended at the Sixteenth Board meeting.

<ol><li> The Board approves for funding for an initial two years, subject to paragraphs 2 and 3 below, the Round 7 proposals recommended for funding by the Technical Review Panel (TRP) and listed in Annex 2 to the Report of the TRP and Secretariat on Round 7 Proposals (GF/B16/5) as:<ol type="i"><li>'Category 1';</li><li>'Category 2'; and</li><li>'Category 2B',</li></ol><br/>with the clear understanding that the grant amounts requested for the "Phase 1 Period" in such Annex are maximum upper ceilings subject to TRP clarifications and grant negotiations rather than final approved grant amounts.</li><li> The applicants whose proposals are recommended for funding as 'Category 1' shall conclude the TRP clarifications process, as indicated by the written approval of the Chair and/or Vice Chair of the TRP, not later than eight weeks after receipt of notification in writing by the Secretariat to the applicant of the Board's decision.</li><li> The applicants whose proposals are recommended for funding as 'Category 2 and Category 2B' shall:<ol type="i"><li>provide an initial detailed written response to the requested TRP clarifications and adjustments by not later than six weeks after receipt of notification in writing by the Secretariat to the applicant of the Board's decision; and</li><li>conclude the TRP clarifications process, as indicated by the written approval of the Chair and Vice Chair of the TRP, not later than three months from the Secretariat's receipt of the applicant's initial detailed response to the issues raised for clarification and/or adjustment.</li></ol></li><li>The Board declines to approve for funding those proposals categorized by the TRP as 'Category 3' as indicated in Annex 2 to GF/B16/5, although such applicants are encouraged to resubmit a proposal in a future funding round after major revision of the relevant proposal.</li><li>The Board declines to approve for funding those proposals categorized by the TRP as 'Category 4' as indicated in Annex 2 to GF/B16/5.</li></ol>

The Board acknowledges the lessons learned by the TRP and Secretariat during the Round 7 proposals process as presented in the Report of Technical Review Panel and the Secretariat on Round 7 Proposals (GF/B16/5), and requests the Portfolio Committee to include appropriate revisions to the Proposal Form and Guidelines for Round 8 by 1 March 2008.

<p>The Board decides that the Secretariat may provide an exception from the decision that grants from the fourth and subsequent Rounds that have a term of less than five years are ineligible for qualification for the Rolling Continuation Channel ("RCC") (GF/B15/DP18) in cases where a Country Coordinating Mechanism ("CCM") <a id="_ftnref1" name="_ftnref1" target="_self"></a>has applied for a grant of five years and the grant term is reduced at the request of the CCM due to accelerated implementation of the program funded by the grant.</p>

<p>The Board takes note of the challenges in operationalizing the Rolling Continuation Channel ("RCC")<a id="_ftnref1" name="_ftnref1">1</a> as set out in the Policy and Strategy Committee document GF/PSC8/05. The Board further notes that the Policy and Strategy Committee has requested the Secretariat to analyze further and develop a Quarterly Application Schedule architecture. It is expected that such long-term architecture changes will be presented to the Board for decision at the Seventeenth Board Meeting.</p><p>As an interim measure to address the specific challenges faced in operationalizing the RCC, the Board approves the procedure for providing additional funding for affected well-performing grants for a time-limited period as set out in Annex 1 (entitled "Interim Bridge Funding for Expiring Grants") to the Report of the Policy and Strategy Committee (GF/B16/6). This interim measure shall apply for relevant grants that fail to qualify for the RCC during the period from initial implementation of the RCC until the adoption by the Board, and full operationalization by the Secretariat, of long-term architectural changes which will address such RCC implementation challenges and that would otherwise experience a funding gap as a direct result of such failure to qualify for the RCC. </p>

<p>The Board refers to its decision at the Fourteenth Board Meeting (GF/B14/DP7) to establish the Rolling Continuation Channel as an alternative funding channel for strongly-performing grants that are reaching the end of their funding terms ("expiring grants").</p> <p>As an interim measure, pending the implementation of the outcomes of the review of the Rolling Continuation Channel architecture, the Board:</p> <ol> <li>Decides to revise the Rolling Continuation Channel policy and procedures in regard to the role of the TRP and the avenues for recourse available to a CCM whose proposal is not recommended for funding after the first submission of a Rolling Continuation Channel proposal by: <ol type="a"> <li>amending paragraph 12 of the decision point (GF/B14/DP9) entitled 'Establishment of a Rolling Continuation Channel' ("RCC decision point") as follows:<br /><br />12. All rolling continuation proposals shall undergo an independent technical review by the TRP. Such review shall ensure that only technically appropriate interventions are funded, with consideration to the fact that the proposal is intended to ensure continued funding for expiring grants that have met the qualification requirements set out in paragraph 3 above.</li> <li>amending paragraphs 7 and 8 of the Board Decision-Making Procedure for the Rolling Continuation Channel (GF/B15/DP19) as follows:<br /><br />7. The effect of a Board decision to approve a TRP recommendation shall be as follows:<br /><br />a. If the Board approves a TRP recommendations to fund a RCC proposal, that decision will constitute an approval of the entire term of such RCC proposal, with a financial commitment for the initial three (3) years of the RCC proposal, with funding for the second phase subject to the approval of the Board based on a mid-term review;<br /><br />b. If, after an initial submission of a given proposal under the RCC, the Board approves a TRP recommendation that the CCM resubmit a revised version of this proposal in the next wave of RCC proposals, the CCM shall have the option to:<br /><br />i. revise its proposal based on the issues identified by the TRP during the initial review of the proposal, and submit the revised proposal in the next wave of Rolling Continuation Channel proposals ("revised proposal"); or<br />ii. file an appeal as described in paragraph c. below<br /><br />If the CCM submits a revised proposal, the procedure described in paragraphs 2-6 above will be followed.<br /><br />c. If the Board approves a TRP recommendation not to fund a proposal, the CCM may file an appeal of the decision not to approve the proposal in accordance with the Global Fund's Rules and Procedures for Appeals as the final avenue for recourse for the unsuccessful RCC proposal.<br /><br />8. If the Board decides not to approve a TRP recommendation to fund, the decision making process that applies following a Board objection to a TRP funding recommendation under the Phase 2 Decision-Making Policies and Procedures, as amended from time to time, will be followed. If the Board objects to a TRP recommendation not to fund, then the matter will be referred to the Board at its next Board meeting.</li> </ol> </li> <li>Amends the description of 'Category 3' recommended proposals set out in Part 2 of Attachment 1 to the Terms of Reference of the Technical Review Panel by splitting 'Category 3' into two parts as follows<br /><br />Category 3a: (Applicable only upon initial submission) Not recommended for funding based on technical merit but strongly encouraged to resubmit a revised proposal, taking into account the issues raised by the TRP, for consideration in the next wave of Rolling Continuation Channel proposals.<br /><br />Category 3b: (Applicable only upon re-submission) Not recommended for funding based on technical merit but encouraged to resubmit through the Rounds-Based Channel following major revision</li> <li>Approves all 'Category 3' recommendations in the Wave 1 TRP Report as if such recommendations were designated 'Category 3a' and requests the Secretariat to notify the relevant CCMs promptly of this decision and the option to resubmit in time for the third wave of RCC proposals</li> <li>Delegates authority to the Secretariat to modify the Rolling Continuation Channel application forms and guidelines to give effect to these modified principles</li> <li>Approves the procedure for providing additional funding ("Rolling Continuation Channel Bridge Funding") for expiring grants as set out in Attachment 1 to Annex 3 of document GF/B16/6.</li> </ol>

<p>The Board refers to its decision<a id="_ftnref1" name="_ftnref1"></a>1 to authorize the Secretariat to modify the application of existing policies to the extent necessary to consolidate grants on a pilot basis. Noting the update on the Secretariat's progress set out in the Policy and Strategy Committee document GF/PSC8/06, the Board reaffirms its commitment to achieving simplification and cost-efficiency in managing grants, and alignment with country systems, while maintaining adherence to the principle of performance-based funding. The Board accordingly delegates to the Secretariat the authority to:</p> <ol start="1" type="1"> <li>work with countries, on a voluntary basis, to consolidate existing and new grants where doing so would be consistent with the principles listed above;</li> <li>exercise flexibility in the application of existing policies, including but not limited to the Phase 2 Decision-Making and the Rolling Continuation Channel policies and procedures,<a id="_ftnref2" name="_ftnref2" target="_self"></a>where necessary, revising requirements that could inhibit grant consolidation; and</li> <li>approve bridge funding, in limited cases and for a period of no longer than nine months, by employing Phase 2 funds not yet approved by the Board, where necessary to allow for the alignment of end dates of grants that are being consolidated, provided that the amount of such bridge funding is reported to the Board on each occasion that it is approved.</li> </ol> <p>The Board requests the Portfolio Committee to ensure that application forms and guidelines allow for the submission of consolidated applications through the Rounds-Based Channel and Rolling Continuation Channel.</p> <p><a id="_ftn1" name="_ftn1"></a></p>

<p>The Board refers to the principles set forth in its decision GF/B15/DP6 and reaffirms that the Global Fund should continue to support the strengthening of public, private and community health systems by investing in activities that help health systems overcome constraints to the achievement of improved outcomes in reducing the burden of HIV/AIDS, tuberculosis and malaria ("ATM").</p> <p>The Board decides that the Global Fund shall provide funding for health systems strengthening ("HSS") actions within the overall framework of funding technically sound proposals focused on the three diseases and that such funding shall be based on the following principles:</p> <ol> <li>The Global Fund shall allow broad flexibility regarding HSS actions eligible for funding, such that they can contribute to system-wide effects and other programs can benefit. With this principle in mind, the Global Fund shall develop guidance with few prescriptions for applications for HSS funding, which may take the form of the following: <ol type="a"> <li>the specification of categories of HSS actions that the Global Fund recommends applicants consider when developing applications for funding;</li> <li>the specification of principles to guide applicants in deciding which categories of HSS actions to apply for; and</li> <li>the specification of any category of HSS actions that may not be financed by the Global Fund.</li> </ol> </li> <li>The Global Fund shall encourage applicants, wherever possible, to integrate requests for funding for HSS actions within the relevant disease component(s). Such HSS actions will be assessed by the Technical Review Panel ("TRP") as part of its review of that disease component.</li> <li>Recognizing that some HSS actions ("cross-cutting HSS actions") may significantly benefit more than one disease, the Global Fund shall allow applicants to request funding for such HSS actions by completing a distinct but complementary section (a "cross-cutting HSS section") within a disease component, provided that: <ol type="a"> <li>An application shall not contain more than one cross-cutting HSS section.</li> <li>Where cross-cutting HSS actions are proposed, the applicant shall articulate how they address identified health systems constraints to the achievement of improved ATM outcomes.</li> </ol> </li> <li>In reviewing a disease component which contains a cross-cutting HSS section, the TRP may recommend for funding either: <ol type="a"> <li>The entire disease component, including the cross-cutting HSS section;</li> <li>The disease component excluding the cross-cutting HSS section; or</li> <li>Only the cross-cutting HSS section if the interventions in that section materially contribute to overcoming health systems constraints to improved ATM outcomes.</li> </ol> </li> <li>The Global Fund shall also: <ol type="a"> <li>Recommend that proposals containing material HSS actions be based on the results of a recent assessment (the coverage of which need not be limited to ATM) identifying health systems constraints to the achievement of improved outcomes in reducing the burden of HIV/AIDS, tuberculosis and malaria; and</li> <li>Recommend that applications provide evidence of the involvement of relevant HSS stakeholders in the Country Coordinating Mechanism - including at least one non-government in-country representative with a focus on HSS and one government representative with responsibility for HSS planning.</li> </ol> </li> </ol> <p>The Board requests the Portfolio Committee to modify future application forms and guidelines (including for the Rolling Continuation Channel), effective from 1 March 2008, to incorporate the above principles and propose for approval at the Seventeenth Board Meeting any modifications to the Terms of Reference of the TRP (including with respect to the composition of the TRP) that are required in light of the strategic approach reflected in this decision point</p> <p>The Board requests the Secretariat to provide to the TRP information on the principles that are set forth in this decision. The Board also requests the Secretariat to communicate clearly, working closely with relevant partners, to country stakeholders the Global Fund's amended strategic approach to HSS - including the flexibilities inherent within it.</p> <p>The Board requests the Secretariat and the TRP to review the results of the Round 8 proposals with regard to HSS actions, and to report to the Eighteenth Board Meeting on the impact of this decision on the application and review process. The report should discuss the quality of proposals that include HSS actions, the proportion recommended by the TRP for approval, and the extent to which applicants have articulated how cross-cutting HSS actions address identified health systems constraints to the achievement of improved ATM outcomes.</p>

The Board approves the Guidelines on Constituency Processes, as detailed in Annex 2 of paper GF/B16/6, and requests that Board Members, Alternate Board Members and Focal Points, along with the Secretariat, ensure these guidelines are shared widely within their respective constituencies, and recommended as a guide to strengthen internal constituency processes.

<p>The Board amends the first sentence of Article 6.3 of the By-laws as follows:</p><p>"The Partnership Forum will meet biennially, at any time during even calendar years".</p>

<p>The Board amends the Key Performance Indicator ("KPI") assessment process approved in GF/B15/DP34 as follows:</p> <p>(a) KPIs for the following year shall be developed and approved by the Policy and Strategy Committee ("PSC"). The PSC shall present the approved KPIs at the last Board meeting of each calendar year.</p> <p>(b) KPIs for 2008 shall exceptionally be reviewed at the PSC's meeting in the first quarter of 2008.</p> <p>All other requirements and timelines set forth in decision GF/B15/DP34 remain unchanged. The PSC shall accordingly assess results achieved against KPIs during the previous year and report on them at the first Board meeting of each calendar year.</p>

<p>The Board acknowledges the letter from the Roll Back Malaria ("RBM") Partnership, dated August 16, 2007 requesting the Global Fund to consider hosting the Affordable Medicines Facility - malaria ("AMFm").</p><p>Based on the information provided to date, the Board supports in principle:</p><ul type="disc"><li>the objectives and principles of AMFm; and</li><li>the idea of investigating with no presumptive decision the appropriateness of hosting the AMFm as a Global Fund business line, considering the complementarities and synergies of the Global Fund's objectives and business model with many design elements of the AMFm.</li></ul><p>To facilitate a final Board decision on hosting the AMFm, the Board requests the Secretariat, under the oversight of the PSC, to develop and present to the Board at its Seventeenth Meeting a report and a possible business model and plan for hosting the AMFm within the Global Fund, taking into account operational and architectural considerations and consultations with the RBM Taskforce, UNITAID, key recipient countries and other relevant stakeholders. The intended mechanism should seek to increase broad access to ACTs especially among those at highest risk.</p>

The Board delegates to the Portfolio Committee the authority to approve the guidelines and proposal forms for each future funding opportunity under both the Rounds-Based Channel and the Rolling Continuation Channel. 

The Board decides to amend the Phase 2 Decision Making Policies and Procedures by adding a new paragraph 19 to the Phase 2 Decision-Making Policy and Procedures as set out in Attachment 1, Section 3 of GF/B16/7.

<p>The Board requests the Portfolio Committee to conduct a review of the Global Fund's quality assurance policy for drugs, taking into account alignment with relevant partners' quality assurance policies, concerns about safety, stability and efficacy of drugs, and market dynamics, and report back to the Board at its Eighteenth Meeting.</p><p>Concerns have been raised about the risk of quality assurance problems with drugs previously covered by the Global Fund's Quality Assurance Policy for Single and Limited Source Products ("Single Source QA Policy") that have recently been re-categorized as multi-source products (GF/B16/7 Revision 1). As an interim measure to address this risk pending the outcome of the review of quality assurance policy, the Board decides that any drugs for the treatment of HIV/AIDS, TB and malaria for which the formula has been published <a id="_ftnref1" name="_ftnref1" target="_self"></a>since the Third Board Meeting (10 October 2002) shall be subject to the Single Source QA Policy.</p><p><a id="_ftn1" name="_ftn1" target="_self"></a></p>

<p>The Board decides to revise the current eligibility criteria for proposals for funding and approves the income level and cost-sharing eligibility criteria for Global Fund funding as set out in Attachment 1, Section 2 of GF/B16/7. The Board delegates to the Portfolio Committee the responsibility to oversee the implementation of the Income Level and Cost-Sharing Eligibility Criteria and to make decisions to facilitate such implementation within the parameters of the policy. The Board further requests technical partners to work with the PC to review how the availability of data for concentrated epidemics in HIV/AIDS will impact access to Global Fund financing. </p><p>The Board decides to review the Income Level and Cost-Sharing Criteria in three years' time. </p>

<p>The Board approves the "Guidelines on the Purpose, Structure, Composition and Funding of Country Coordinating Mechanisms and Requirements for Grant Eligibility" ("CCM Guidelines") as outlined in Attachment 1, Section 1 of GF/B16/7 (Revision 1). </p><p>In the context of DP/B15/14 the Board requests the Portfolio Committee to continue to review the representation and participation of civil society and private sector on CCMs and delegates to the Portfolio Committee the authority to modify the CCM Guidelines to make membership of key affected populations and other civil society and private sector representatives on the CCM a requirement if the Portfolio Committee deems it appropriate based on its review.</p><p>The Board approves an allocation of US$ 5,961,000 for CCM funding for the period ending on 31 December 2008. The Board emphasizes that this funding must be used in accordance with the CCM funding policy and is a maximum only. The Board requests that the Secretariat include the expected annual CCM funding maximum as part of the annual budget for the Secretariat that is reviewed by the Finance and Audit Committee and approved by the Board at the last Board Meeting of each calendar year, by adding a separate line item within the operating costs in the same manner as the LFA oversight cost.</p><p>The Board delegates to the Portfolio Committee the responsibility for overseeing the implementation of the CCM funding policy and grants to the Portfolio Committee the authority to make such modifications to the CCM Guidelines as may be necessary to operationalize the funding policy. The Portfolio Committee will provide updates on any such modifications in its periodic reports to the Board.</p><p>The Board also requests the Portfolio Committee to work with the Secretariat to identify future alternative models of CCM funding taking into consideration (i) the intended purpose and role of CCMs, (ii) differing country contexts, (iii) the need for meaningful participation by civil society representatives, and (iv) the need to strengthen and support the capacity and resources of CCMs to conduct grant oversight and (v) harmonization with other national bodies. If appropriate based on the outcome of this work, the Portfolio Committee shall recommend modifications to the CCM composition functioning and financing for decision by the Board at its Eighteenth Meeting.</p>

The Board approves the 2008 Operating Expense budget in the amount of US$ 176,610,000 as set out in Annex 1 to the Report of the Finance and Audit Committee GF/B16/8 and proposed by the Secretariat. 

<p>The Board decides that the Global Fund shall discontinue the Administrative Services Agreement with the World Health Organization not later than December 31, 2008 (the "End Date"). Administrative and employment arrangements that will be in effect after that date shall be determined in accordance with the principles, processes and timelines that are described in Annex 2 to the Report of the Finance and Audit Committee GF/B16/8. </p><p>Pursuant to the above, the Board requests the Secretariat to propose a new cash balance pension scheme that shall provide safeguards for the interests of staff, to which Global Fund staff can be affiliated beginning on the date of termination of the WHO Administrative Services Agreement (the "GF Pension Fund"), and delegates authority to the Finance and Audit Committee to approve it by its March 2008 meeting.</p><p>The Secretariat shall notify the United Nations Joint Staff Pension Fund through the WHO that the Global Fund wishes to negotiate a transfer agreement between the UNJSPF and the GF Pension Fund, for submission to the July 2008 session of the UNJSPF Board.</p><p>The Board takes note of the need to further clarify the relationship and partnership with the WHO and the UN system after a discontinuation of the administrative services agreement with WHO, based on a true public/private identity as an efficient and attractive financing instrument and the role of the UN, including its normative role and function. It requests that a draft policy statement on the relationship and partnership with the WHO and the UN system, linked to the broader PSC review of partnership relations, is presented at the 17th Board Meeting.</p>

The Board approves the Policy for Disclosure of Reports Issued by the Inspector General, set out in Annex 3 to the Report of the Finance and Audit Committee GF/B16/8.

<p>The Board thanks the Inspector General ad interim for his work on the development of the Global Fund Assurance Framework, and requests the incoming Inspector General to further develop the Assurance Framework for approval at the Seventeenth Board Meeting.</p><p>The Board requests the Secretariat to develop a Risk Management Framework in collaboration with the incoming Inspector General for review by the FAC in March 2008 (subject to the priorities to be established). </p><p>The Board requests the incoming Inspector General to develop a list of priorities for consideration by the Finance and Audit Committee for inclusion in the 2008 work plan of the Office of the Inspector General that will be presented to the Seventeenth Board Meeting. </p>

The Global Fund to Fight AIDS, Tuberculosis and Malaria will not hold Board or Committee Meetings in countries that restrict short-term entry of people living with HIV/AIDS and/or require prospective HIV-positive visitors to declare their HIV status on visa application forms or other documentation required for entry into the country.

<p>Following GF/B16/DP24 the Board strongly encourages all countries to move rapidly towards elimination of travel/entry restrictions, including waivers, for people living with HIV. The Board acknowledges the UNAIDS commitment to create a Task Team with the aim of eliminating policies and practices that restrict travel for HIV positive people.</p>

<p>The Board recognizes the importance of addressing gender issues, with a particular focus on the vulnerabilities of women and girls and sexual minorities, in the fight against the three diseases, more substantially into the Global Fund's policies and operations. </p><p>The Board authorizes the Secretariat as a matter of priority to immediately appoint senior level "Champions for Gender Equality", with appropriate support, who will:</p><p>a. Work with technical partners and relevant constituencies to develop a gender strategy.</p><p>b. As an immediate priority, provide guidance to the Portfolio Committee on revisions to the Guidelines for Proposals for Round 8 to encourage applicants to submit proposals that address gender issues, with a particular reference to the vulnerability of women and girls and sexual minorities.</p><p>The Board requests the Policy and Strategy Committee to review the Gender Strategy and present it to the Board for approval at the Seventeenth Board meeting.</p>

<ol><li>The Board approves additional funding for the Phase 2 period for the proposals listed in Schedule A in the amounts indicated for each proposal, with the clear understanding that the amounts approved are upper ceilings rather than final funding amounts, and based on an understanding that the Secretariat shall pursue ongoing implementation arrangements for each proposal consistent with the recommendations set forth in its Grant Scorecard.<br/><br/>The Board reaffirms that the maximum funding amount for Phase 2 of each proposal shall be the sum of the amount approved by this decision and the amount of any funds approved for Phase 1 which have not been disbursed by the Global Fund at the end of the Phase 1 period.<br/><br/>SCHEDULE A (Phase 2 Decision)<br/><br/>Rwanda, HSS – Round 4<br/>Grant Number(s): RWN-505-G05-S<br/>CCM Requested Amount (Total Phase 2 in US$) 19,622,213<br/>Approved Funding Amount (Incremental in US$) 19,622,213<br/>Recommendation Category: Go2. <br/><br/>South Africa, HIV/TB – Round 2<br/>Grant Number(s): SAF-202-G05-C-00<br/>CCM Requested Amount (Total Phase 2 in US$) 17,563,541(1)<br/>Approved Funding Amount (Incremental in US$) 15,986,220<br/>Recommendation Category: Conditional Go3. <br/><br/>Swaziland, HIV – Round 4<br/>Grant Number(s): SWZ-405-G04-H<br/>CCM Requested Amount (Total Phase 2 in US$) 34,273,541(1)<br/>Approved Funding Amount (Incremental in US$) 29,442,921<br/>Recommendation Category: <br/>Conditional Go<br/><br/></li><li>The Board approves Exceptional Extension Funding for the proposal listed in Schedule B in the amount and period indicated for the proposal, with the clear understanding that the amount approved is an upper ceiling rather than a final funding amount.<br/><br/>SCHEDULE B (Exceptional Extension Funding Decision)<br/><br/>Burundi, Malaria – Round 2<br/>Grant Number(s): BRN-202-G05-M<br/>Duration of Funding: 5 months<br/>CCM Requested Amount (in US$) 3,492,712<br/>Approved Funding Amount (Incremental in US$) 1,267,367<br/><br/></li><li>The Board approves the use of undisbursed grant funds under grant number TMP-304-G02-T to finance the continuity of services listed in Schedule C and described in Annex 1, with the clear understanding that the amount approved is an upper ceiling rather than a final funding amount, and based on an understanding that the Secretariat shall pursue implementation arrangements for such proposal consistent with the recommendation set forth in Annex 1.<br/><br/>SCHEDULE C (Continuity of Services Decision)<br/><br/>Timor Leste, TB – Round 3<br/>Grant Number(s): TMP-304-G02-T<br/>CCM Requested Amount (in US$) 36,560<br/>Approved Funding Amount (Incremental in US$) 0</li></ol>

<ol><li>The Board approves additional funding for the Phase 2 period for the proposal listed in Schedule A in the amount indicated for the proposal, with the clear understanding that the amount approved is an upper ceiling rather than the final funding amount, and based on an understanding that the Secretariat shall pursue ongoing implementation arrangements for the proposal consistent with the recommendations set forth in its Grant Scorecard.The Board reaffirms that the maximum funding amount for Phase 2 of the proposal shall be the sum of the amount approved by this decision and the amount of any funds approved for Phase 1 which have not been disbursed by the Global Fund at the end of the Phase 1 period.<br/><br/></li><li>The Board approves additional funding for the Phase 2 period of the Round 4 Togo Malaria grant (TGO-405-G05-M) as a ‘Conditional Go’ in the amount of up to US$4,628,947 subject to TRP clarifications within a limited timeframe and to conditions to be cleared by the Secretariat.The Board reaffirms that the maximum funding amount for Phase 2 of this grant shall be the sum of the amount approved by this decision and the amount of any funds approved for Phase 1 which have not been disbursed by the Global Fund at the end of the Phase 1 period.<br/><br/>SCHEDULE A<br/><br/>Rwanda, Malaria – Round 5<br/>Grant Number: RWN-506-G06-M<br/>CCM Requested Amount (Total Phase 2 in US$) 11,508,591<br/>Approved Funding Amount (Incremental in US$) 11,508,591<br/>Recommendation Category: Conditional Go</li></ol>

<p>The Board approved for funding for an initial two years in the amounts indicated and subject to paragraph 2 below, the following Round 7 proposals that were recommended for funding by the Independent Appeal Panel in its report dated 8 February 2008:</p><ul><li>Azerbaijan (Malaria) – Euro 2,544,154; <br/><br/></li><li>Cambodia (Tuberculosis) – USD 8,707,480; and<br/><br/></li><li>Zambia (Tuberculosis) – USD 4,112,419.</li></ul><p>With the clear understanding that the amounts indicated are upper ceilings subject to Technical Review Panel (TRP) clarifications and grant negotiations, rather than final approved grant amounts.</p><p>The applicants referred to in paragraph 1 above shall:</p><ul><li>provide an initial detailed written response to the clarifications and adjustments requested by the Independent Appeal Panel by not later than six weeks after notification in writing by the Secretariat to the applicant of the Board’s decision; and</li><li>conclude the clarification process, as indicated by the written approval of the Chair or Vice Chair of the TRP not later than three months from the Secretariat’s receipt of the applicants initial detailed response to the issues raised for clarifications or adjustments.</li></ul>

<ol><li>The Board approves additional funding for the Phase 2 period for the proposals listed in Schedule A in the amounts indicated for each proposal, with the clear understanding that the amounts approved are upper ceilings rather than final funding amounts, and based on an understanding that the Secretariat shall pursue ongoing implementation arrangements for each proposal consistent with the recommendations set forth in its Grant Scorecard.<br/><br/>The Board reaffirms that the maximum funding amount for Phase 2 of each proposal shall be the sum of the amount approved by this decision and the amount of any funds approved for Phase 1 which have not been disbursed by the Global Fund at the end of the Phase 1 period.<br/><br/></li><li>The Board approves a 3-month extension to the deadline for the satisfaction of the following condition in the Yemen Round 3 HIV Grant Score Card[1]:<br/><br/>Within 12 months of Board approval of continued funding, the Principal Recipient shall provide evidence to the Global Fund that it has met at least 80% of the targets for that period contained in the proposal for each of the following indicators:<br/><br/>Number of PLWHA receiving antiretroviral combination therapy; <br/>Number of people receiving VCT; <br/>Number of high risk vulnerable persons reached with IEC activities; <br/>Number of staff trained in behavioral surveillance; and Number of service deliverers trained in IEC, BCC community outreach, VCT, STD, ART, care and support. Should these targets not be met by September 2008, all further funding of this proposal shall cease.<br/><br/>The revised deadline to meet the condition is set at 31 December 2008.<br/><br/><br/>SCHEDULE A<br/><br/>Kosovo, TB – Round 4<br/>Grant Number(s): KOS-405-G01-T<br/>CCM Requested Amount (Total Phase 2 in US$): 1,830,050<br/>Approved Funding Amount (Incremental in US$): 1,830,050<br/>Recommendation Category: Go<br/><br/>Macedonia, TB – Round 5<br/>Grant Number(s): MKD-506-G02-T<br/>CCM Requested Amount (Total Phase 2 in US$): 1,628,608<br/>Approved Funding Amount (Incremental in US$): 1,628,608<br/>Recommendation Category: Go<br/><br/>Malawi, Malaria – Round 2<br/>Grant Number(s): MLW-202-G02-M<br/>CCM Requested Amount (Total Phase 2 in US$): 19,674,096(1)<br/>Approved Funding Amount (Incremental in US$): 18,816,000<br/>Recommendation Category: Conditional Go<br/><br/>Tajikistan, Malaria – Round 5<br/>Grant Number(s): TAJ-506-G04-M<br/>CCM Requested Amount (Total Phase 2 in US$): 2,611,509<br/>Approved Funding Amount (Incremental in US$): 2,611,509<br/>Recommendation Category: Go</li></ol>

<ol><li>The Board approves additional funding for the Phase 2 period for the proposals listed in Schedule A in the amounts indicated for each proposal, with the clear understanding that the amounts approved are upper ceilings rather than final funding amounts, and based on an understanding that the Secretariat shall pursue ongoing implementation arrangements for each proposal consistent with the recommendations set forth in its Grant Scorecard.<br/><br/>The Board reaffirms that the maximum funding amount for Phase 2 of each proposal shall be the sum of the amount approved by this decision and the amount of any funds approved for Phase 1 which have not been disbursed by the Global Fund at the end of the Phase 1 period.<br/><br/></li><li>The Board approves the use of undisbursed grant funds under grant number IND-102-G01-T-00 listed in Schedule B to finance continuation of program activities under the Rolling Continuation Interim Bridge Funding policy, with the clear understanding that the amount approved is an upper ceiling rather than a final funding amount, and based on an understanding that the Secretariat shall pursue implementation arrangements for such proposal consistent with the recommendations set forth in the Qualification Score Card.<br/><br/><br/>SCHEDULE A (Phase 2 Recommendations)<br/><br/>Ghana, HIV – Round 5<br/>Grant Number(s) GHN-506-G06-H<br/>CCM Requested Amount (Total Phase 2 in US$): 65,468,580<br/>Approved Funding Amount (Incremental in US$): 65,468,580<br/>Recommendation Category: Go<br/><br/>Ghana, TB – Round 5<br/>Grant Number(s) GHN-506-G05-T<br/>CCM Requested Amount (Total Phase 2 in US$): 17,916,308(1)<br/>Approved Funding Amount (Incremental in US$): 16,924,238<br/>Recommendation Category: Go<br/><br/>Kenya, Malaria – Round 4<br/>Grant Number(s) KEN-405-G06-M<br/>CCM Requested Amount (Total Phase 2 in US$): 104,346,797<br/>Approved Funding Amount (Incremental in US$): 80,423,329<br/>Recommendation Category: Conditional Go<br/><br/>Kyrgyzstan, Malaria – Round 5<br/>Grant Number(s) KGZ-506-G03-M<br/>CCM Requested Amount (Total Phase 2 in US$): 1,733,735<br/>Approved Funding Amount (Incremental in US$): 1,733,735<br/>Recommendation Category: Go<br/><br/>Uganda, Malaria – Round 4<br/>Grant Number(s): UGD-405-G05-M<br/>CCM Requested Amount (Total Phase 2 in US$): 91,614,931<br/>Approved Funding Amount (Incremental in US$): 71,034,989<br/>Recommendation <br/>Category: Conditional Go<br/><br/>Zambia, HIV – Round 4<br/>Grant Number(s): ZAM-405-G12-H<br/>CCM Requested Amount (Total Phase 2 in US$): 21,687,283<br/>Approved Funding Amount (Incremental in US$): 13,390,445<br/>Recommendation<br/>Category: Conditional Go<br/><br/><br/>SCHEDULE B (RCC Interim Bridge Funding Recommendation)<br/><br/>Indonesia, TB – Round 1<br/>Grant Number(s): IND-102-G01-T-00<br/>Duration of Funding: 10 months<br/>CCM Requested Amount (Incremental in US$): 0<br/>Approved Funding Amount (Incremental in US$) 0</li></ol>